author-photo

Dan Theodorescu

University of Virginia
University of Colorado Boulder
Department of Urology, University of Virginia

318

Papers

12989

Citations

Citation Trend

Filter By

Papers (223) Sort By

Journal Conference Others

The Potential of Combination Therapies and Patient Stratification to Improve CCR2 Inhibition Therapeutics

2021
- Jason E. Duex
- Dan Theodorescu
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 614: Transcriptomic analysis of BCG-treated T1HG bladder cancer patients identifies an EMT-basal subgroup with immune suppressive characteristics at high risk of BCG-failure

2021
Show All
- Source
- Cite
- Save
Citations (0)
Transcriptome sequencing of BCG-treated T1HG bladder cancer patients identifies an EMT-basal subgroup with immune suppressive characteristics at high risk of BCG failure

2021 European Urology
Show All
- Source
- Cite
- Save
Citations (0)
The Origin of Bladder Cancer from Mucosal Field Effects

2021 bioRxiv
Show All
- Source
- Cite
- Save
Citations (0)
A pilot clinical trial of genomic-based therapy assignment with co-expression extrapolation (COXEN) in advanced/metastatic urothelial carcinoma.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Improving Anti-PD-1/PD-L1 Therapy for Localized Bladder Cancer

2021 International Journal of Molecular Sciences
Show All
- Source
- Cite
- Save
Citations (2)
Abstract IA10: Developing rational combination therapy with checkpoint inhibitors

2020
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 4091: Functional genomic screening in gemcitabine and cisplatin resistant bladder cancer cell lines identifies DNA repair pathways as mediators of chemosensitivity

2020
Show All
- Source
- Cite
- Save
Citations (0)
Targeting DDR2 enhances tumor response to anti–PD-1 immunotherapy

2019 Science Advances
Show All
- Source
- Cite
- Save
Citations (42)
Precision Medicine in Bladder Cancer

2019 Oncology Times UK
Show All
- Source
- Cite
- Save
Citations (0)